Justices Refuse Bids To Stop Apotex's Benicar Patent Suit
The U.S. Supreme Court on Monday refused drugmakers Mylan's and Daiichi's bids to review a Federal Circuit decision letting Apotex pursue a declaration that an Apotex generic would not infringe a...To view the full article, register now.
Already a subscriber? Click here to view full article